Literature DB >> 31875248

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.

Kai Zhang1,2, Akemi Sakamoto3, Lijia Chang1, Youge Qu1, Siming Wang1, Yaoyu Pu1, Yunfei Tan1, Xingming Wang1, Yuko Fujita1, Tamaki Ishima1, Masahiko Hatano3, Kenji Hashimoto4.   

Abstract

The spleen is a large immune organ that plays a key role in the immune system. The precise molecular mechanisms underlying the relationship between the spleen and stress-related psychiatric disorders are unknown. Here we investigated the role of spleen in stress-related psychiatric disorders. FACS analysis was applied to determine the contribution of the spleen to susceptibility and resilience in mice that were subjected to chronic social defeat stress (CSDS). We found a notable increase in splenic volume and weight in CSDS-susceptible mice compared to control (no CSDS) mice and CSDS-resilient mice. The number of granulocytes, but not of T cells and B cells, in the spleen of susceptible mice was higher than in the spleen of both control and resilient mice. Interestingly, NKG2D (natural killer group 2, member D) expression in the spleen of CSDS-susceptible mice was higher than that in control mice and CSDS-resilient mice. In addition, NKG2D expression in the spleen of patients with depression was higher than that in controls. Both increased splenic weight and increased splenic NKG2D expression in CSDS-susceptible mice were ameliorated after a subsequent administration of (R)-ketamine. The present findings indicate a novel role of splenic NKG2D in stress susceptibility versus resilience in mice subjected to CSDS. Furthermore, abnormalities in splenic functions in CSDS-susceptible mice were ameliorated after subsequent injection of (R)-ketamine. Thus, the brain-spleen axis might, at least in part, contribute to the pathogenesis of stress-related psychiatric disorders such as depression.

Entities:  

Keywords:  (R)-ketamine; Antidepressant; Brain–spleen axis; NKG2D; Spleen

Year:  2019        PMID: 31875248      PMCID: PMC7981328          DOI: 10.1007/s00406-019-01092-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  54 in total

Review 1.  NKG2D ligands: key targets of the immune response.

Authors:  Segundo González; Alejandro López-Soto; Beatriz Suarez-Alvarez; Antonio López-Vázquez; Carlos López-Larrea
Journal:  Trends Immunol       Date:  2008-07-03       Impact factor: 16.687

2.  Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder.

Authors:  Zhongwei Xiong; Kai Zhang; Qian Ren; Lijia Chang; Jincao Chen; Kenji Hashimoto
Journal:  J Affect Disord       Date:  2018-11-05       Impact factor: 4.839

Review 3.  The NKG2D axis: an emerging target in cancer immunotherapy.

Authors:  Mariya Lazarova; Alexander Steinle
Journal:  Expert Opin Ther Targets       Date:  2019-02-22       Impact factor: 6.902

4.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

Review 5.  Psychobiology and molecular genetics of resilience.

Authors:  Adriana Feder; Eric J Nestler; Dennis S Charney
Journal:  Nat Rev Neurosci       Date:  2009-06       Impact factor: 34.870

6.  Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway.

Authors:  Michael T Bailey; Harald Engler; Nicole D Powell; David A Padgett; John F Sheridan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-27       Impact factor: 3.619

7.  Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.

Authors:  Chao Dong; Ji-Chun Zhang; Wei Yao; Qian Ren; Min Ma; Chun Yang; Shigeyuki Chaki; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2017-03-01       Impact factor: 5.176

Review 8.  The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.

Authors:  Marina Babic; Chiara Romagnani
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

Review 9.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

Review 10.  Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.

Authors:  Chun Yang; Jianjun Yang; Ailin Luo; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222

View more
  10 in total

1.  Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation.

Authors:  Yaoyu Pu; Qiuping Zhang; Zhigang Tang; Chenyang Lu; Liang Wu; Yutong Zhong; Yuehong Chen; Kenji Hashimoto; Yubin Luo; Yi Liu
Journal:  Transl Psychiatry       Date:  2022-06-01       Impact factor: 7.989

Review 2.  Science's Response to CoVID-19.

Authors:  Marcus J C Long; Yimon Aye
Journal:  ChemMedChem       Date:  2021-06-22       Impact factor: 3.540

3.  Characterizing the behavioral and neuroendocrine features of susceptibility and resilience to social stress.

Authors:  Dalia Murra; Kathryn L Hilde; Anne Fitzpatrick; Pamela M Maras; Stanley J Watson; Huda Akil
Journal:  Neurobiol Stress       Date:  2022-02-12

4.  Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.

Authors:  Wei Yao; Qianqian Cao; Shilin Luo; Lujuan He; Chun Yang; Jiaxu Chen; Qi Qi; Kenji Hashimoto; Ji-Chun Zhang
Journal:  Mol Psychiatry       Date:  2021-11-24       Impact factor: 13.437

5.  Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice.

Authors:  Hiroyo Shinno-Hashimoto; Akifumi Eguchi; Akemi Sakamoto; Xiayun Wan; Yaeko Hashimoto; Yuko Fujita; Chisato Mori; Masahiko Hatano; Hiroyuki Matsue; Kenji Hashimoto
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

Review 6.  Immunoregulation and antidepressant effect of ketamine.

Authors:  Nan Zhang; Lihua Yao; Peilin Wang; Zhongchun Liu
Journal:  Transl Neurosci       Date:  2021-05-26       Impact factor: 1.757

7.  A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration.

Authors:  Jiancheng Zhang; Li Ma; Lijia Chang; Yaoyu Pu; Youge Qu; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2020-06-09       Impact factor: 6.222

8.  Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine.

Authors:  Li Ma; Jiancheng Zhang; Yuko Fujita; Youge Qu; Jiajing Shan; Xiayun Wan; Xingming Wang; Tamaki Ishima; Kenta Kobayashi; Long Wang; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2022-01-21       Impact factor: 7.989

Review 9.  Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.

Authors:  Yan Wei; Lijia Chang; Kenji Hashimoto
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

10.  Red light exaggerated sepsis-induced learning impairments and anxiety-like behaviors.

Authors:  Bing Xie; Yujing Zhang; Hong Qi; Hua Yao; You Shang; Shiying Yuan; Jiancheng Zhang
Journal:  Aging (Albany NY)       Date:  2020-11-10       Impact factor: 5.955

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.